| Product Code: ETC9968793 | Publication Date: Sep 2024 | Updated Date: Aug 2025 | Product Type: Market Research Report | |
| Publisher: 6Wresearch | Author: Vasudha | No. of Pages: 75 | No. of Figures: 35 | No. of Tables: 20 |
1 Executive Summary |
2 Introduction |
2.1 Key Highlights of the Report |
2.2 Report Description |
2.3 Market Scope & Segmentation |
2.4 Research Methodology |
2.5 Assumptions |
3 United States (US) Knee Osteoarthritis Market Overview |
3.1 United States (US) Country Macro Economic Indicators |
3.2 United States (US) Knee Osteoarthritis Market Revenues & Volume, 2021 & 2031F |
3.3 United States (US) Knee Osteoarthritis Market - Industry Life Cycle |
3.4 United States (US) Knee Osteoarthritis Market - Porter's Five Forces |
3.5 United States (US) Knee Osteoarthritis Market Revenues & Volume Share, By Treatment Type, 2021 & 2031F |
3.6 United States (US) Knee Osteoarthritis Market Revenues & Volume Share, By Route of Administration, 2021 & 2031F |
3.7 United States (US) Knee Osteoarthritis Market Revenues & Volume Share, By Dosage Form, 2021 & 2031F |
3.8 United States (US) Knee Osteoarthritis Market Revenues & Volume Share, By Diagnosis, 2021 & 2031F |
3.9 United States (US) Knee Osteoarthritis Market Revenues & Volume Share, By End-Users, 2021 & 2031F |
3.10 United States (US) Knee Osteoarthritis Market Revenues & Volume Share, By Distribution Channel, 2021 & 2031F |
4 United States (US) Knee Osteoarthritis Market Dynamics |
4.1 Impact Analysis |
4.2 Market Drivers |
4.2.1 Increasing aging population in the United States leading to a higher prevalence of knee osteoarthritis |
4.2.2 Growing awareness about the importance of early diagnosis and treatment of knee osteoarthritis |
4.2.3 Technological advancements in knee osteoarthritis treatment options improving patient outcomes |
4.3 Market Restraints |
4.3.1 High treatment costs associated with knee osteoarthritis management |
4.3.2 Limited insurance coverage for certain advanced treatment options |
4.3.3 Regulatory challenges impacting the introduction of new therapies in the market |
5 United States (US) Knee Osteoarthritis Market Trends |
6 United States (US) Knee Osteoarthritis Market, By Types |
6.1 United States (US) Knee Osteoarthritis Market, By Treatment Type |
6.1.1 Overview and Analysis |
6.1.2 United States (US) Knee Osteoarthritis Market Revenues & Volume, By Treatment Type, 2021- 2031F |
6.1.3 United States (US) Knee Osteoarthritis Market Revenues & Volume, By Medication, 2021- 2031F |
6.1.4 United States (US) Knee Osteoarthritis Market Revenues & Volume, By Surgery, 2021- 2031F |
6.1.5 United States (US) Knee Osteoarthritis Market Revenues & Volume, By Therapy, 2021- 2031F |
6.2 United States (US) Knee Osteoarthritis Market, By Route of Administration |
6.2.1 Overview and Analysis |
6.2.2 United States (US) Knee Osteoarthritis Market Revenues & Volume, By Oral, 2021- 2031F |
6.2.3 United States (US) Knee Osteoarthritis Market Revenues & Volume, By Parenteral, 2021- 2031F |
6.2.4 United States (US) Knee Osteoarthritis Market Revenues & Volume, By Others, 2021- 2031F |
6.3 United States (US) Knee Osteoarthritis Market, By Dosage Form |
6.3.1 Overview and Analysis |
6.3.2 United States (US) Knee Osteoarthritis Market Revenues & Volume, By Tablets, 2021- 2031F |
6.3.3 United States (US) Knee Osteoarthritis Market Revenues & Volume, By Injections, 2021- 2031F |
6.3.4 United States (US) Knee Osteoarthritis Market Revenues & Volume, By Others, 2021- 2031F |
6.4 United States (US) Knee Osteoarthritis Market, By Diagnosis |
6.4.1 Overview and Analysis |
6.4.2 United States (US) Knee Osteoarthritis Market Revenues & Volume, By Imaging Tests, 2021- 2031F |
6.4.3 United States (US) Knee Osteoarthritis Market Revenues & Volume, By Joint Fluid Analysis, 2021- 2031F |
6.4.4 United States (US) Knee Osteoarthritis Market Revenues & Volume, By Blood Tests, 2021- 2031F |
6.4.5 United States (US) Knee Osteoarthritis Market Revenues & Volume, By Others, 2021- 2031F |
6.5 United States (US) Knee Osteoarthritis Market, By End-Users |
6.5.1 Overview and Analysis |
6.5.2 United States (US) Knee Osteoarthritis Market Revenues & Volume, By Hospitals, 2021- 2031F |
6.5.3 United States (US) Knee Osteoarthritis Market Revenues & Volume, By Specialty Clinics, 2021- 2031F |
6.5.4 United States (US) Knee Osteoarthritis Market Revenues & Volume, By Homecare, 2021- 2031F |
6.5.5 United States (US) Knee Osteoarthritis Market Revenues & Volume, By Others, 2021- 2031F |
6.6 United States (US) Knee Osteoarthritis Market, By Distribution Channel |
6.6.1 Overview and Analysis |
6.6.2 United States (US) Knee Osteoarthritis Market Revenues & Volume, By Hospital Pharmacy, 2021- 2031F |
6.6.3 United States (US) Knee Osteoarthritis Market Revenues & Volume, By Retail Pharmacy, 2021- 2031F |
6.6.4 United States (US) Knee Osteoarthritis Market Revenues & Volume, By Online Pharmacy, 2021- 2031F |
6.6.5 United States (US) Knee Osteoarthritis Market Revenues & Volume, By Others, 2021- 2031F |
7 United States (US) Knee Osteoarthritis Market Import-Export Trade Statistics |
7.1 United States (US) Knee Osteoarthritis Market Export to Major Countries |
7.2 United States (US) Knee Osteoarthritis Market Imports from Major Countries |
8 United States (US) Knee Osteoarthritis Market Key Performance Indicators |
8.1 Average waiting time for knee osteoarthritis diagnosis and treatment |
8.2 Patient satisfaction rates with different treatment modalities |
8.3 Number of clinical trials and research studies focused on knee osteoarthritis |
8.4 Adoption rate of minimally invasive procedures for knee osteoarthritis management |
9 United States (US) Knee Osteoarthritis Market - Opportunity Assessment |
9.1 United States (US) Knee Osteoarthritis Market Opportunity Assessment, By Treatment Type, 2021 & 2031F |
9.2 United States (US) Knee Osteoarthritis Market Opportunity Assessment, By Route of Administration, 2021 & 2031F |
9.3 United States (US) Knee Osteoarthritis Market Opportunity Assessment, By Dosage Form, 2021 & 2031F |
9.4 United States (US) Knee Osteoarthritis Market Opportunity Assessment, By Diagnosis, 2021 & 2031F |
9.5 United States (US) Knee Osteoarthritis Market Opportunity Assessment, By End-Users, 2021 & 2031F |
9.6 United States (US) Knee Osteoarthritis Market Opportunity Assessment, By Distribution Channel, 2021 & 2031F |
10 United States (US) Knee Osteoarthritis Market - Competitive Landscape |
10.1 United States (US) Knee Osteoarthritis Market Revenue Share, By Companies, 2024 |
10.2 United States (US) Knee Osteoarthritis Market Competitive Benchmarking, By Operating and Technical Parameters |
11 Company Profiles |
12 Recommendations |
13 Disclaimer |
Export potential enables firms to identify high-growth global markets with greater confidence by combining advanced trade intelligence with a structured quantitative methodology. The framework analyzes emerging demand trends and country-level import patterns while integrating macroeconomic and trade datasets such as GDP and population forecasts, bilateral import–export flows, tariff structures, elasticity differentials between developed and developing economies, geographic distance, and import demand projections. Using weighted trade values from 2020–2024 as the base period to project country-to-country export potential for 2030, these inputs are operationalized through calculated drivers such as gravity model parameters, tariff impact factors, and projected GDP per-capita growth. Through an analysis of hidden potentials, demand hotspots, and market conditions that are most favorable to success, this method enables firms to focus on target countries, maximize returns, and global expansion with data, backed by accuracy.
By factoring in the projected importer demand gap that is currently unmet and could be potential opportunity, it identifies the potential for the Exporter (Country) among 190 countries, against the general trade analysis, which identifies the biggest importer or exporter.
To discover high-growth global markets and optimize your business strategy:
Click Here